NM_207341.4:c.319G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_207341.4(ZP1):​c.319G>A​(p.Asp107Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00202 in 1,600,752 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/26 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 15 hom. )

Consequence

ZP1
NM_207341.4 missense, splice_region

Scores

2
17
Splicing: ADA: 0.9251
2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.75

Publications

6 publications found
Variant links:
Genes affected
ZP1 (HGNC:13187): (zona pellucida glycoprotein 1) The zona pellucida is an extracellular matrix that surrounds the oocyte and early embryo. It is composed primarily of three or four glycoproteins with various functions during fertilization and preimplantation development. The protein encoded by this gene ensures the structural integrity of the zona pellucida. Mutations in this gene are a cause of oocyte maturation defect and infertility. [provided by RefSeq, May 2014]
ZP1 Gene-Disease associations (from GenCC):
  • female infertility due to zona pellucida defect
    Inheritance: AR, AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0063221753).
BP6
Variant 11-60869537-G-A is Benign according to our data. Variant chr11-60869537-G-A is described in ClinVar as Benign. ClinVar VariationId is 2641815.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00196 (298/152254) while in subpopulation AMR AF = 0.0034 (52/15292). AF 95% confidence interval is 0.00266. There are 1 homozygotes in GnomAd4. There are 151 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 15 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZP1NM_207341.4 linkc.319G>A p.Asp107Asn missense_variant, splice_region_variant Exon 3 of 12 ENST00000278853.10 NP_997224.2 P60852V9HWI9
ZP1XM_011544853.3 linkc.-198+271G>A intron_variant Intron 1 of 9 XP_011543155.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZP1ENST00000278853.10 linkc.319G>A p.Asp107Asn missense_variant, splice_region_variant Exon 3 of 12 1 NM_207341.4 ENSP00000278853.5 P60852
ZP1ENST00000540908.1 linkn.108+271G>A intron_variant Intron 1 of 2 5 ENSP00000441293.1 H0YG11

Frequencies

GnomAD3 genomes
AF:
0.00196
AC:
298
AN:
152136
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00340
Gnomad ASJ
AF:
0.0202
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00210
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00253
AC:
616
AN:
243100
AF XY:
0.00246
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00282
Gnomad ASJ exome
AF:
0.0202
Gnomad EAS exome
AF:
0.00125
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00244
Gnomad OTH exome
AF:
0.00322
GnomAD4 exome
AF:
0.00203
AC:
2935
AN:
1448498
Hom.:
15
Cov.:
31
AF XY:
0.00205
AC XY:
1473
AN XY:
718740
show subpopulations
African (AFR)
AF:
0.000270
AC:
9
AN:
33306
American (AMR)
AF:
0.00308
AC:
136
AN:
44152
Ashkenazi Jewish (ASJ)
AF:
0.0205
AC:
515
AN:
25170
East Asian (EAS)
AF:
0.000582
AC:
23
AN:
39518
South Asian (SAS)
AF:
0.000839
AC:
71
AN:
84664
European-Finnish (FIN)
AF:
0.0000568
AC:
3
AN:
52860
Middle Eastern (MID)
AF:
0.0163
AC:
93
AN:
5702
European-Non Finnish (NFE)
AF:
0.00170
AC:
1874
AN:
1103360
Other (OTH)
AF:
0.00353
AC:
211
AN:
59766
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
171
341
512
682
853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00196
AC:
298
AN:
152254
Hom.:
1
Cov.:
32
AF XY:
0.00203
AC XY:
151
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41534
American (AMR)
AF:
0.00340
AC:
52
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0202
AC:
70
AN:
3472
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5184
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00210
AC:
143
AN:
68016
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00271
Hom.:
4
Bravo
AF:
0.00238
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00279
AC:
24
ExAC
AF:
0.00217
AC:
263
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ZP1: BP4, BS1, BS2 -

ZP1-related disorder Benign:1
May 15, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.061
T
Eigen
Benign
-0.030
Eigen_PC
Benign
-0.063
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.60
T
M_CAP
Benign
0.0084
T
MetaRNN
Benign
0.0063
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
L
PhyloP100
1.8
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.083
Sift
Uncertain
0.019
D
Sift4G
Benign
0.13
T
Polyphen
0.84
P
Vest4
0.078
MVP
0.46
MPC
0.20
ClinPred
0.026
T
GERP RS
4.3
Varity_R
0.073
gMVP
0.52
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.93
dbscSNV1_RF
Benign
0.68
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.24
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145707301; hg19: chr11-60637010; API